{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:20:18Z","timestamp":1790508018621,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["Memoriam Grant"],"award-info":[{"award-number":["Memoriam Grant"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Steroid-resistant nephrotic syndrome (SRNS) is the second leading cause of chronic kidney disease (CKD) in childhood. It represents a heterogeneous group of diseases with variable kidney outcomes that are still challenging to predict. In this study, our main objective is to describe predictive factors of remission states and kidney survival comparing genetic and non-genetic SRNS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We conducted a retrospective analysis of 65 pediatric patients with SRNS treated at the pediatric outpatient clinic in Berlin between 2000 and 2023. Clinical characteristics, laboratory findings, and treatment strategies were systematically collected at multiple time points. Outcomes were defined by remission status, kidney survival (CKD stage I\u2013IV), or progression to CKD stage V. Statistical analyses included univariate and multivariate logistic and Cox regression models adjusted for monogenic SRNS to identify predictors of remission and kidney survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The median age of onset was 4.0\u00a0years, with a male predominance of 57%. Patients were followed for a median of 5.9\u00a0years. At the last follow-up, 26 patients achieved complete remission, 12 achieved partial remission, and 27 showed no remission. Kidney survival rates at 5 and 10\u00a0years were 71% and 56%, respectively. High initial nephrotic-range proteinuria, confirmed genetic diagnoses, reduced eGFR, and hypoalbuminemia at 3-month and 1-year follow-ups were identified as negative predictive factors for complete or partial remission. These factors also correlated strongly with an elevated risk of progression to CKD stage V.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our findings highlight additional prognostic factors influencing remission status and long-term kidney survival in pediatric SRNS, emphasizing the value of detailed early time-point analyses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1007\/s00467-025-06705-5","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T21:37:46Z","timestamp":1740778666000},"page":"2239-2252","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Outcomes and prognostic factors in childhood-onset steroid-resistant nephrotic syndrome: a retrospective single-center study"],"prefix":"10.1007","volume":"40","author":[{"given":"Emil","family":"Zerkowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutta","family":"Gellermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Beckus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Holle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Kempf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Bufler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Thumfart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1180-0794","authenticated-orcid":false,"given":"Verena","family":"Kl\u00e4mbt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,1]]},"reference":[{"key":"6705_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/s0140-6736(18)30536-1","volume":"392","author":"DG Noone","year":"2018","unstructured":"Noone DG, Iijima K, Parekh R (2018) Idiopathic nephrotic syndrome in children. Lancet 392:61\u201374. https:\/\/doi.org\/10.1016\/s0140-6736(18)30536-1","journal-title":"Lancet"},{"key":"6705_CR2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","volume":"362","author":"AA Eddy","year":"2003","unstructured":"Eddy AA, Symons JM (2003) Nephrotic syndrome in childhood. Lancet 362:629\u2013639. https:\/\/doi.org\/10.1016\/S0140-6736(03)14184-0","journal-title":"Lancet"},{"key":"6705_CR3","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s00467-020-04519-1","volume":"35","author":"A Trautmann","year":"2020","unstructured":"Trautmann A, Vivarelli M, Samuel S, Gipson D, Sinha A, Schaefer F, Hui NK, Boyer O, Saleem MA, Feltran L, M\u00fcller-Deile J, Becker JU, Cano F, Xu H, Lim YN, Smoyer W, Anochie I, Nakanishi K, Hodson E, Haffner D, International Pediatric Nephrology Association (2020) IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome. Pediatr Nephrol 35:1529\u20131561. https:\/\/doi.org\/10.1007\/s00467-020-04519-1","journal-title":"Pediatr Nephrol"},{"key":"6705_CR4","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1080\/20469047.2017.1374003","volume":"37","author":"ML Downie","year":"2017","unstructured":"Downie ML, Gallibois C, Parekh RS, Noone DG (2017) Nephrotic syndrome in infants and children: pathophysiology and management. Paediatr Int Child Health 37:248\u2013258. https:\/\/doi.org\/10.1080\/20469047.2017.1374003","journal-title":"Paediatr Int Child Health"},{"key":"6705_CR5","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1016\/j.ekir.2021.05.001","volume":"6","author":"D Ying","year":"2021","unstructured":"Ying D, Liu W, Chen L, Rong L, Lin Z, Wen S, Zhuang H, Li J, Jiang X (2021) Long-term outcome of secondary steroid-resistant nephrotic syndrome in Chinese children. Kidney Int Rep 6:2144\u20132150. https:\/\/doi.org\/10.1016\/j.ekir.2021.05.001","journal-title":"Kidney Int Rep"},{"key":"6705_CR6","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1111\/j.1523-1755.2005.00524.x","volume":"68","author":"JS Kim","year":"2005","unstructured":"Kim JS, Bellew CA, Silverstein DM, Aviles DH, Boineau FG, Vehaskari VM (2005) High incidence of initial and late steroid resistance in childhood nephrotic syndrome. Kidney Int 68:1275\u20131281. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00524.x","journal-title":"Kidney Int"},{"key":"6705_CR7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/ndt\/gfz185","volume":"36","author":"M Sato","year":"2021","unstructured":"Sato M, Ishikura K, Ando T, Kikunaga K, Terano C, Hamada R, Ishimori S, Hamasaki Y, Araki Y, Gotoh Y, Nakanishi K, Nakazato H, Matsuyama T, Iijima K, Yoshikawa N, Ito S, Honda M, Japanese Pediatric Survey Holding Information of Nephrotic Syndrome (JP-SHINE) study of the Japanese Study Group of Renal Disease in Children (2021) Prognosis and acute complications at the first onset of idiopathic nephrotic syndrome in children: a nationwide survey in Japan (JP-SHINE study). Nephrol Dial Transplant 36:475\u2013481. https:\/\/doi.org\/10.1093\/ndt\/gfz185","journal-title":"Nephrol Dial Transplant"},{"key":"6705_CR8","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1681\/ASN.2013080852","volume":"25","author":"WY Ding","year":"2014","unstructured":"Ding WY, Koziell A, McCarthy HJ, Bierzynska A, Bhagavatula MK, Dudley JA, Inward CD, Coward RJ, Tizard J, Reid C, Antignac C, Boyer O, Saleem MA (2014) Initial steroid sensitivity in children with steroid-resistant nephrotic syndrome predicts post-transplant recurrence. J Am Soc Nephrol 25:1342\u20131348. https:\/\/doi.org\/10.1681\/ASN.2013080852","journal-title":"J Am Soc Nephrol"},{"key":"6705_CR9","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s00467-009-1138-5","volume":"24","author":"D Mekahli","year":"2009","unstructured":"Mekahli D, Liutkus A, Ranchin B, Yu A, Bessenay L, Girardin E, Van Damme-Lombaerts R, Palcoux J-B, Cachat F, Lavocat M-P, Bourdat-Michel G, Nobili F, Cochat P (2009) Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter study. Pediatr Nephrol 24:1525\u20131532. https:\/\/doi.org\/10.1007\/s00467-009-1138-5","journal-title":"Pediatr Nephrol"},{"key":"6705_CR10","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1681\/ASN.2016101121","volume":"28","author":"A Trautmann","year":"2017","unstructured":"Trautmann A, Schnaidt S, Lipska-Zi\u0119tkiewicz BS, Bodria M, Ozaltin F, Emma F, Anarat A, Melk A, Azocar M, Oh J, Saeed B, Gheisari A, Caliskan S, Gellermann J, Higuita LMS, Jankauskiene A, Drozdz D, Mir S, Balat A, Szczepanska M, Paripovic D, Zurowska A, Bogdanovic R, Yilmaz A, Ranchin B, Baskin E, Erdogan O, Remuzzi G, Firszt-Adamczyk A, Kuzma-Mroczkowska E, Litwin M, Murer L, Tkaczyk M, Jardim H, Wasilewska A, Printza N, Fidan K, Simkova E, Borzecka H, Staude H, Hees K, Schaefer F, PodoNet Consortium (2017) Long-term outcome of steroid-resistant nephrotic syndrome in children. J Am Soc Nephrol 28:3055\u20133065. https:\/\/doi.org\/10.1681\/ASN.2016101121","journal-title":"J Am Soc Nephrol"},{"key":"6705_CR11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00467-006-0301-5","volume":"22","author":"KH Paik","year":"2007","unstructured":"Paik KH, Lee BH, Cho HY, Kang HG, Ha IS, Cheong HI, Jin D-K, Moon KC, Choi Y (2007) Primary focal segmental glomerular sclerosis in children: clinical course and prognosis. Pediatr Nephrol 22:389\u2013395. https:\/\/doi.org\/10.1007\/s00467-006-0301-5","journal-title":"Pediatr Nephrol"},{"key":"6705_CR12","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1681\/ASN.2014050489","volume":"26","author":"CE Sadowski","year":"2015","unstructured":"Sadowski CE, Lovric S, Ashraf S, Pabst WL, Gee HY, Kohl S, Engelmann S, Vega-Warner V, Fang H, Halbritter J, Somers MJ, Tan W, Shril S, Fessi I, Lifton RP, Bockenhauer D, El-Desoky S, Kari JA, Zenker M, Kemper MJ, Mueller D, Fathy HM, Soliman NA, SRNS Study Group, Hildebrandt F (2015) A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J Am Soc Nephrol 26:1279\u20131289. https:\/\/doi.org\/10.1681\/ASN.2014050489","journal-title":"J Am Soc Nephrol"},{"key":"6705_CR13","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s00467-010-1495-0","volume":"25","author":"G Benoit","year":"2010","unstructured":"Benoit G, Machuca E, Antignac C (2010) Hereditary nephrotic syndrome: a systematic approach for genetic testing and a review of associated podocyte gene mutations. Pediatr Nephrol 25:1621\u20131632. https:\/\/doi.org\/10.1007\/s00467-010-1495-0","journal-title":"Pediatr Nephrol"},{"key":"6705_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2147\/phmt.s100803","volume":"8","author":"N Nourbakhsh","year":"2017","unstructured":"Nourbakhsh N, Mak R (2017) Steroid-resistant nephrotic syndrome: past and current perspectives. Pediatric Health Med Ther 8:29\u201337. https:\/\/doi.org\/10.2147\/phmt.s100803","journal-title":"Pediatric Health Med Ther"},{"key":"6705_CR15","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s00467-017-3634-3","volume":"32","author":"M Atmaca","year":"2017","unstructured":"Atmaca M, Gulhan B, Korkmaz E, Inozu M, Soylemezoglu O, Candan C, Bayaz\u0131t AK, Elmac\u0131 AM, Parmaksiz G, Duzova A, Besbas N, Topaloglu R, Ozaltin F (2017) Follow-up results of patients with ADCK4 mutations and the efficacy of CoQ10 treatment. Pediatr Nephrol 32:1369\u20131375. https:\/\/doi.org\/10.1007\/s00467-017-3634-3","journal-title":"Pediatr Nephrol"},{"key":"6705_CR16","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1172\/JCI45693","volume":"121","author":"SF Heeringa","year":"2011","unstructured":"Heeringa SF, Chernin G, Chaki M, Zhou W, Sloan AJ, Ji Z, Xie LX, Salviati L, Hurd TW, Vega-Warner V, Killen PD, Raphael Y, Ashraf S, Ovunc B, Schoeb DS, McLaughlin HM, Airik R, Vlangos CN, Gbadegesin R, Hinkes B, Saisawat P, Trevisson E, Doimo M, Casarin A, Pertegato V, Giorgi G, Prokisch H, R\u00f6tig A, N\u00fcrnberg G, Becker C, Wang S, Ozaltin F, Topaloglu R, Bakkaloglu A, Bakkaloglu SA, M\u00fcller D, Beissert A, Mir S, Berdeli A, Varpizen S, Zenker M, Matejas V, Santos-Oca\u00f1a C, Navas P, Kusakabe T, Kispert A, Akman S, Soliman NA, Krick S, Mundel P, Reiser J, N\u00fcrnberg P, Clarke CF, Wiggins RC, Faul C, Hildebrandt F (2011) COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J Clin Invest 121:2013\u20132024. https:\/\/doi.org\/10.1172\/JCI45693","journal-title":"J Clin Invest"},{"key":"6705_CR17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2215\/CJN.07370715","volume":"11","author":"AK B\u00fcscher","year":"2016","unstructured":"B\u00fcscher AK, Beck BB, Melk A, Hoefele J, Kranz B, Bamborschke D, Baig S, Lange-Sperandio B, Jungraithmayr T, Weber LT, Kemper MJ, T\u00f6nshoff B, Hoyer PF, Konrad M, Weber S, German Pediatric Nephrology Association (GPN) (2016) Rapid response to cyclosporin A and favorable renal outcome in nongenetic versus genetic steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 11:245\u2013253. https:\/\/doi.org\/10.2215\/CJN.07370715","journal-title":"Clin J Am Soc Nephrol"},{"key":"6705_CR18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3389\/fped.2018.00200","volume":"6","author":"A Trautmann","year":"2018","unstructured":"Trautmann A, Lipska-Zi\u0119tkiewicz BS, Schaefer F (2018) Exploring the clinical and genetic spectrum of steroid resistant nephrotic syndrome: the PodoNet Registry. Front Pediatr 6:200. https:\/\/doi.org\/10.3389\/fped.2018.00200","journal-title":"Front Pediatr"},{"key":"6705_CR19","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1007\/s00467-024-06382-w","volume":"39","author":"K Priyanka","year":"2024","unstructured":"Priyanka K, Deepthi B, Krishnasamy S, Ganesh RN, Sravani M, Krishnamurthy S (2024) Kidney outcomes in children with primary focal segmental glomerulosclerosis from a low- and middle- income country. Pediatr Nephrol 39:3485\u20133495. https:\/\/doi.org\/10.1007\/s00467-024-06382-w","journal-title":"Pediatr Nephrol"},{"key":"6705_CR20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.5527\/wjn.v12.i5.159","volume":"12","author":"A Raza","year":"2023","unstructured":"Raza A, Nawaz SH, Rashid R, Ahmed E, Mubarak M (2023) The correlation of spot urinary protein-to-creatinine ratio with 24-h urinary protein excretion in various glomerulopathies. World J Nephrol 12:159\u2013167. https:\/\/doi.org\/10.5527\/wjn.v12.i5.159","journal-title":"World J Nephrol"},{"key":"6705_CR21","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Mu\u00f1oz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629\u2013637. https:\/\/doi.org\/10.1681\/ASN.2008030287","journal-title":"J Am Soc Nephrol"},{"key":"6705_CR22","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group","year":"2021","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group (2021) KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int 100:S1\u2013S276. https:\/\/doi.org\/10.1016\/j.kint.2021.05.021","journal-title":"Kidney Int"},{"key":"6705_CR23","doi-asserted-by":"publisher","first-page":"983","DOI":"10.2215\/CJN.13371019","volume":"15","author":"AE Mason","year":"2020","unstructured":"Mason AE, Sen ES, Bierzynska A, Colby E, Afzal M, Dorval G, Koziell AB, Williams M, Boyer O, Welsh GI, Saleem MA, UK RaDaR\/NephroS Study (2020) Response to first course of intensified immunosuppression in genetically stratified steroid resistant nephrotic syndrome. Clin J Am Soc Nephrol 15:983\u2013994. https:\/\/doi.org\/10.2215\/CJN.13371019","journal-title":"Clin J Am Soc Nephrol"},{"key":"6705_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1590\/2175-8239-JBN-2022-0073en","volume":"45","author":"OP Mishra","year":"2023","unstructured":"Mishra OP, Sidar M, Batra VV, Prasad R, Singh A, Abhinay A, Mishra A, Yadav AK (2023) Outcomes of children with idiopathic steroid resistant nephrotic syndrome: a single centre observational study. J Bras Nefrol 45:199\u2013209. https:\/\/doi.org\/10.1590\/2175-8239-JBN-2022-0073en","journal-title":"J Bras Nefrol"},{"key":"6705_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s43054-024-00267-1","volume":"72","author":"YAH Elbeltagi","year":"2024","unstructured":"Elbeltagi YAH, Kersh MMEDE, Fathy HM, Kamel NA-S (2024) Study of steroid-resistant nephrotic syndrome: a single center experience. Egyptian Pediatric Association Gazette 72:35. https:\/\/doi.org\/10.1186\/s43054-024-00267-1","journal-title":"Egyptian Pediatric Association Gazette"},{"key":"6705_CR26","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1007\/s00467-021-05135-3","volume":"36","author":"R Ehren","year":"2021","unstructured":"Ehren R, Benz MR, Brinkk\u00f6tter PT, D\u00f6tsch J, Eberl WR, Gellermann J, Hoyer PF, Jordans I, Kamrath C, Kemper MJ, Latta K, M\u00fcller D, Oh J, T\u00f6nshoff B, Weber S, Weber LT, German Society for Pediatric Nephrology (2021) Pediatric idiopathic steroid-sensitive nephrotic syndrome: diagnosis and therapy -short version of the updated German best practice guideline (S2e) - AWMF register no. 166\u2013001, 6\/2020. Pediatr Nephrol 36:2971\u20132985. https:\/\/doi.org\/10.1007\/s00467-021-05135-3","journal-title":"Pediatr Nephrol"},{"key":"6705_CR27","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1093\/ndt\/gfr572","volume":"27","author":"J Gellermann","year":"2012","unstructured":"Gellermann J, Ehrich JHH, Querfeld U (2012) Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome. Nephrol Dial Transplant 27:1970\u20131978. https:\/\/doi.org\/10.1093\/ndt\/gfr572","journal-title":"Nephrol Dial Transplant"},{"key":"6705_CR28","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.2215\/CJN.01190210","volume":"5","author":"AK B\u00fcscher","year":"2010","unstructured":"B\u00fcscher AK, Kranz B, B\u00fcscher R, Hildebrandt F, Dworniczak B, Pennekamp P, Kuwertz-Br\u00f6king E, Wingen A-M, John U, Kemper M, Monnens L, Hoyer PF, Weber S, Konrad M (2010) Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 5:2075\u20132084. https:\/\/doi.org\/10.2215\/CJN.01190210","journal-title":"Clin J Am Soc Nephrol"},{"key":"6705_CR29","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00467-010-1468-3","volume":"25","author":"J Gellermann","year":"2010","unstructured":"Gellermann J, Stefanidis CJ, Mitsioni A, Querfeld U (2010) Successful treatment of steroid-resistant nephrotic syndrome associated with WT1 mutations. Pediatr Nephrol 25:1285\u20131289. https:\/\/doi.org\/10.1007\/s00467-010-1468-3","journal-title":"Pediatr Nephrol"},{"key":"6705_CR30","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nm.1857","volume":"14","author":"C Faul","year":"2008","unstructured":"Faul C, Donnelly M, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, Chang J-M, Choi HY, Campbell KN, Kim K, Reiser J, Mundel P (2008) The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 14:931\u2013938. https:\/\/doi.org\/10.1038\/nm.1857","journal-title":"Nat Med"},{"key":"6705_CR31","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/s41581-019-0217-5","volume":"15","author":"MA Saleem","year":"2019","unstructured":"Saleem MA (2019) Molecular stratification of idiopathic nephrotic syndrome. Nat Rev Nephrol 15:750\u2013765. https:\/\/doi.org\/10.1038\/s41581-019-0217-5","journal-title":"Nat Rev Nephrol"},{"key":"6705_CR32","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s13052-024-01817-4","volume":"50","author":"S Li","year":"2024","unstructured":"Li S, He C, Sun Y, Chen J, Liu Y, Huang Z, Huang W, Meng Y, Liu W, Lei X, Zhao R, Lin Z, Huang C, Lei F, Qin Y (2024) Clinical characteristics and prognosis of steroid-resistant nephrotic syndrome in children: a multi-center retrospective study. Ital J Pediatr 50:242. https:\/\/doi.org\/10.1186\/s13052-024-01817-4","journal-title":"Ital J Pediatr"},{"key":"6705_CR33","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1007\/s00467-024-06422-5","volume":"39","author":"S Yokota","year":"2024","unstructured":"Yokota S, Kamei K, Fujinaga S, Hamada R, Inaba A, Nishi K, Sato M, Ogura M, Sakuraya K, Ito S (2024) Efficacy of rituximab and risk factors for poor prognosis in patients with childhood-onset steroid-resistant nephrotic syndrome: a multicenter study. Pediatr Nephrol 39:2979\u20132988. https:\/\/doi.org\/10.1007\/s00467-024-06422-5","journal-title":"Pediatr Nephrol"},{"key":"6705_CR34","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1681\/ASN.2010010063","volume":"21","author":"HJ Lambers Heerspink","year":"2010","unstructured":"Lambers Heerspink HJ, Gansevoort RT, Brenner BM, Cooper ME, Parving HH, Shahinfar S, de Zeeuw D (2010) Comparison of different measures of urinary protein excretion for prediction of renal events. J Am Soc Nephrol 21:1355\u20131360. https:\/\/doi.org\/10.1681\/ASN.2010010063","journal-title":"J Am Soc Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06705-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-025-06705-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06705-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T10:03:45Z","timestamp":1757498625000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-025-06705-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["6705"],"URL":"https:\/\/doi.org\/10.1007\/s00467-025-06705-5","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,1]]},"assertion":[{"value":"13 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approved by the Ethics Committee of the Charit\u00e9 at Campus Virchow-Klinikum (EA2\/239\/22), which waived the need for informed consent due to the retrospective design of the study (for ethical proposal and approval, see Supplementary Information).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}